Editas Medicine, Inc.
EDIT
$2.80
-$0.035-1.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -41.97% | -48.37% | -58.64% | 150.95% | 247.03% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -41.97% | -48.37% | -58.64% | 150.95% | 247.03% |
| Cost of Revenue | -34.75% | -6.14% | 12.16% | 37.54% | 32.41% |
| Gross Profit | 31.44% | -18.44% | -67.73% | -16.94% | -3.14% |
| SG&A Expenses | -9.42% | 0.06% | 3.35% | -4.23% | -10.00% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -28.69% | -4.53% | 9.68% | 24.44% | 19.00% |
| Operating Income | 24.51% | -11.89% | -41.22% | -9.52% | 1.39% |
| Income Before Tax | -22.44% | -51.22% | -54.74% | -7.94% | 6.00% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -22.44% | -51.22% | -54.74% | -7.94% | 6.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.44% | -51.22% | -54.74% | -7.94% | 6.00% |
| EBIT | 24.51% | -11.89% | -41.22% | -9.52% | 1.39% |
| EBITDA | 25.65% | -12.07% | -42.91% | -9.95% | 1.21% |
| EPS Basic | -20.76% | -44.57% | -39.94% | 5.47% | 20.53% |
| Normalized Basic EPS | 18.79% | -15.22% | -34.01% | 6.20% | 21.20% |
| EPS Diluted | -20.76% | -44.57% | -39.94% | 5.47% | 20.53% |
| Normalized Diluted EPS | 18.79% | -15.22% | -34.01% | 6.20% | 21.20% |
| Average Basic Shares Outstanding | 1.51% | 4.35% | 8.46% | 12.97% | 17.92% |
| Average Diluted Shares Outstanding | 1.51% | 4.35% | 8.46% | 12.97% | 17.92% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |